ArticleInternal medicine (Tokyo, Japan)2017

Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids.

Masato Sawamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.